Metrics as of 10/17/2026, 07:16 AM (Berlin time), refresh in progress.
AdaptHealth Stock
AdaptHealth Corp.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Suzanne Foster
- Employees
- 10,900
- Market cap
- $821 M
- IPO
- 31/05/2018
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea.…
AdaptHealth stock: price history
1D
-5.8%
1W
-0.7%
1M
+1.9%
6M
-52.4%
YTD
-39.6%
1Y
-34.1%
2Y
-44.6%
5Y
-76.2%
10Y
–
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~165% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about AdaptHealth
Analyst assessment of AdaptHealth
PRICE TARGET LOW
US$8.00
CONSENSUS
US$9.83
MEDIAN
US$9.50
PRICE TARGET HIGH
US$13.00
0
STRONG BUY
9
BUY
2
HOLD
1
SELL
0
STRONG SELL
12
TOTAL · Buy
As of: 17/09/2026
AdaptHealth stock metrics
P/E
-3.58
P/B
0.59
EV/EBITDA
9.78
RETURN ON EQUITY
-9.7%
NET MARGIN
-18.1%
DEBT/EQUITY
1.5
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
63.3%
FLOAT SHARES
86,354,699
AVG. DAILY VOLUME (30D)
2,495,298
Insider transactions (SEC)
CURRIE HARRISS T
WOLF DALE B
SAMET KENNETH A
WOLF DALE B
Schuster III Russell E.
Institutional holders
Comparable stocks
Frequently asked questions about AdaptHealth stock
What does AdaptHealth do?
AdaptHealth Corp. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Suzanne Foster, the company employs around 10,900 people.
The IPO was on 31/05/2018; the stock trades on NASDAQ under the ticker AHCO.
What do analysts say about AdaptHealth stock?
12 analysts rate the stock, the consensus is Buy (as of 17/09/2026).
The average price target is US$9.83, ranging from US$8.00 to US$13.00, with a median of US$9.50.
This is an external assessment, not a statement by Market Jury.
When does AdaptHealth report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 165% stronger than usual.
Does AdaptHealth pay a dividend?
No, AdaptHealth currently does not pay a dividend.
Which stocks are comparable to AdaptHealth?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get AdaptHealth stock analyzed?
Clicking "Analyze stock" lets five strategies assess AdaptHealth against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.